Published in Biophys J on March 02, 2011
Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU. Mol Microbiol (2011) 1.13
Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa. PLoS Pathog (2012) 1.00
Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review. Crit Care (2014) 0.96
Structure of the type III secretion effector protein ExoU in complex with its chaperone SpcU. PLoS One (2012) 0.89
Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase. J Biol Chem (2013) 0.88
Cooperative substrate-cofactor interactions and membrane localization of the bacterial PLA2 enzyme, ExoU. J Biol Chem (2017) 0.77
Structure and Dynamics of Type III Secretion Effector Protein ExoU As determined by SDSL-EPR Spectroscopy in Conjunction with De Novo Protein Folding. ACS Omega (2017) 0.75
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis (2004) 20.99
Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20
Type III secretion machines: bacterial devices for protein delivery into host cells. Science (1999) 9.10
Protein delivery into eukaryotic cells by type III secretion machines. Nature (2006) 7.49
Identifying conformational changes with site-directed spin labeling. Nat Struct Biol (2000) 5.76
Dead-time free measurement of dipole-dipole interactions between electron spins. J Magn Reson (2000) 5.26
High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation. Proc Natl Acad Sci U S A (2008) 5.06
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol (1997) 4.94
Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis (2001) 4.06
A new spin on protein dynamics. Trends Biochem Sci (2002) 3.72
Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med (2002) 3.63
Molecular architecture of the KvAP voltage-dependent K+ channel in a lipid bilayer. Science (2004) 3.59
The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol (2009) 3.56
Molecular motion of spin labeled side chains in alpha-helices: analysis by variation of side chain structure. Biochemistry (2001) 3.45
Structural studies on transmembrane proteins. 2. Spin labeling of bacteriorhodopsin mutants at unique cysteines. Biochemistry (1989) 3.25
Recent advances and applications of site-directed spin labeling. Curr Opin Struct Biol (2006) 3.12
The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J (2003) 3.10
Measuring distances by pulsed dipolar ESR spectroscopy: spin-labeled histidine kinases. Methods Enzymol (2007) 2.76
Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci U S A (2008) 2.68
Structure and dynamics of a helical hairpin and loop region in annexin 12: a site-directed spin labeling study. Biochemistry (2002) 1.99
In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors. J Biol Chem (2003) 1.84
Methods and applications of site-directed spin labeling EPR spectroscopy. Methods Cell Biol (2008) 1.72
Osmolyte perturbation reveals conformational equilibria in spin-labeled proteins. Protein Sci (2009) 1.60
Conformational cycle of the ABC transporter MsbA in liposomes: detailed analysis using double electron-electron resonance spectroscopy. J Mol Biol (2009) 1.56
Conformational states and dynamics of rhodopsin in micelles and bilayers. Biochemistry (2006) 1.51
Type III secretion/intoxication system important in virulence of Pseudomonas aeruginosa infections in burns. Burns (2001) 1.51
Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU. J Bacteriol (2001) 1.35
Spectroscopic evidence that osmolytes used in crystallization buffers inhibit a conformation change in a membrane protein. Biochemistry (2003) 1.30
CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection. Curr Opin Microbiol (2002) 1.29
Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU. Infect Immun (2005) 1.25
Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin, ExoU. J Bacteriol (2005) 1.23
Substrate-dependent unfolding of the energy coupling motif of a membrane transport protein determined by double electron-electron resonance. Biochemistry (2006) 1.20
Solutes modify a conformational transition in a membrane transport protein. Biophys J (2006) 1.20
Identification of superoxide dismutase as a cofactor for the pseudomonas type III toxin, ExoU. Biochemistry (2006) 1.18
Monitoring inhibitor-induced conformational population shifts in HIV-1 protease by pulsed EPR spectroscopy. Biochemistry (2009) 1.18
PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice. Infect Immun (2001) 1.16
Eukaryotic localization, activation and ubiquitinylation of a bacterial type III secreted toxin. Cell Microbiol (2006) 1.13
A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells. Infect Immun (2006) 1.09
Structure of the cytoplasmic domain of erythrocyte band 3 hereditary spherocytosis variant P327R: band 3 Tuscaloosa. Biochemistry (2007) 1.00
The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit. J Trauma (2007) 0.99
Morbidity associated with Pseudomonas aeruginosa bloodstream infections. Diagn Microbiol Infect Dis (2009) 0.94
Activation of ExoU phospholipase activity requires specific C-terminal regions. J Bacteriol (2010) 0.92
Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity. Infect Immun (2010) 0.91
Functionally important ATP binding and hydrolysis sites in Escherichia coli MsbA. Biochemistry (2008) 0.90
A sensitive fluorescence-based assay for the detection of ExoU-mediated PLA(2) activity. Clin Chim Acta (2009) 0.88
The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J (2003) 3.10
Construction and characterization of a highly efficient Francisella shuttle plasmid. Appl Environ Microbiol (2004) 2.71
ExoU is a potent intracellular phospholipase. Mol Microbiol (2004) 2.71
Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis. Infect Immun (2003) 2.70
Methods and applications of site-directed spin labeling EPR spectroscopy. Methods Cell Biol (2008) 1.72
Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic alpha-helical antimicrobial peptides. Biochim Biophys Acta (2006) 1.62
Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Infect Immun (2006) 1.50
Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages. Infect Immun (2007) 1.49
Acquisition and evolution of the exoU locus in Pseudomonas aeruginosa. J Bacteriol (2006) 1.40
A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge. PLoS One (2008) 1.39
Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis. PLoS One (2010) 1.26
Deamidation, but not truncation, decreases the urea stability of a lens structural protein, betaB1-crystallin. Biochemistry (2002) 1.25
Paradoxical cAMP-induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY. Circ Res (2004) 1.24
Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin, ExoU. J Bacteriol (2005) 1.23
Type IV pili in Francisella tularensis: roles of pilF and pilT in fiber assembly, host cell adherence, and virulence. Infect Immun (2008) 1.19
Identification of superoxide dismutase as a cofactor for the pseudomonas type III toxin, ExoU. Biochemistry (2006) 1.18
Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU. Mol Microbiol (2011) 1.13
Membrane binding, structure, and localization of cecropin-mellitin hybrid peptides: a site-directed spin-labeling study. Biophys J (2004) 1.06
Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU. Infect Immun (2006) 1.04
Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria. Front Microbiol (2011) 1.03
Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa. J Infect Dis (2002) 0.98
Membrane-anchoring and charge effects in the interaction of myelin basic protein with lipid bilayers studied by site-directed spin labeling. J Biol Chem (2003) 0.98
Membrane insertion and bilayer perturbation by antimicrobial peptide CM15. Biophys J (2007) 0.97
An immunodominant epitope of myelin basic protein is an amphipathic alpha-helix. J Biol Chem (2003) 0.95
Osmoprotection of bacterial cells from toxicity caused by antimicrobial hybrid peptide CM15. Biochemistry (2006) 0.94
Five mechanisms of manipulation by bacterial effectors: a ubiquitous theme. PLoS Pathog (2012) 0.94
Filamin A is a phosphorylation target of membrane but not cytosolic adenylyl cyclase activity. Am J Physiol Lung Cell Mol Physiol (2011) 0.92
Activation of ExoU phospholipase activity requires specific C-terminal regions. J Bacteriol (2010) 0.92
Membrane fluidity profiles as deduced by saturation-recovery EPR measurements of spin-lattice relaxation times of spin labels. J Magn Reson (2011) 0.91
Modified needle-tip PcrV proteins reveal distinct phenotypes relevant to the control of type III secretion and intoxication by Pseudomonas aeruginosa. PLoS One (2011) 0.89
A sensitive fluorescence-based assay for the detection of ExoU-mediated PLA(2) activity. Clin Chim Acta (2009) 0.88
Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase. J Biol Chem (2013) 0.88
Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity. Antimicrob Agents Chemother (2008) 0.84
In the absence of effector proteins, the Pseudomonas aeruginosa type three secretion system needle tip complex contributes to lung injury and systemic inflammatory responses. PLoS One (2013) 0.84
Pseudomonas aeruginosa exotoxin Y-mediated tau hyperphosphorylation impairs microtubule assembly in pulmonary microvascular endothelial cells. PLoS One (2013) 0.84
Physical properties of lipid bilayers from EPR spin labeling and their influence on chemical reactions in a membrane environment. Free Radic Biol Med (2008) 0.83
Disruption of LptA oligomerization and affinity of the LptA-LptC interaction. Protein Sci (2013) 0.83
Site-directed mutagenesis studies of human serum albumin define tryptophan at amino acid position 214 as the principal site for nitrosation. J Biomed Sci (2002) 0.77
A Budding-Defective M2 Mutant Exhibits Reduced Membrane Interaction, Insensitivity to Cholesterol, and Perturbed Interdomain Coupling. Biochemistry (2017) 0.75
In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins. Methods Mol Biol (2014) 0.75